Benztropine 0.5 mg Tablets — Generic For Cogentin — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Benztropine mesylate tablets are prescription tablets for oral use. The label says they are used as an adjunct in the therapy of all forms of parkinsonism and also for control of extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

The tablets contain benztropine mesylate in strengths of 0.5 mg, 1 mg, or 2 mg. The label notes that benztropine has anticholinergic and antihistaminic effects, with the anticholinergic effect considered therapeutically significant in parkinsonism.

Important safety information on the label includes caution about use in pediatric patients, warning that the medicine may impair the ability to do hazardous tasks such as driving or operating machinery, and the need to watch for heat-related problems, urinary retention, confusion, hallucinations, and other anticholinergic side effects.

Storage Information

Store at 20° to 25° C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in well-closed containers as defined in the USP.

Key Counseling Points

• Take this medicine only as directed on the prescription label.
• It is used for parkinsonism and for some movement problems caused by neuroleptic drugs.
• Do not use this medicine if you have a hypersensitivity to benztropine mesylate or any tablet ingredient.
• The label says it should not be used in children under 3 years of age.
• This medicine may affect mental or physical abilities needed for driving or operating machinery.
• Report gastrointestinal complaints, fever, or heat intolerance promptly if this medicine is taken with certain other drugs.
• Watch for dry mouth, constipation, nausea, vomiting, urinary retention, blurred vision, or dilated pupils.
• Seek prompt attention for confusion, hallucinations, unusual excitement, or worsening mental symptoms.
• The label warns about heat-related problems such as anhidrosis, hyperthermia, heat stroke, and severe anhidrosis.
• Tell a healthcare professional about any history of glaucoma, prostatic hypertrophy, tachycardia, or urinary problems.

Helpful Patient Education

Benztropine mesylate tablets USP are oral tablets available in 0.5 mg, 1 mg, and 2 mg strengths. According to the DailyMed label, this medicine is used as an adjunct in the therapy of all forms of parkinsonism and may also be used to help control extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

The label includes important safety information about anticholinergic side effects, possible impairment of mental or physical abilities, and the need to watch for urinary retention, dry mouth, blurred vision, confusion, and heat-related reactions. Product information also lists inactive ingredients and tablet descriptions for identification.

Medication Summary last generated: 2026-07-10 02:57:58